| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/14/2010 | WO2010006183A2 Measuring lipoprotein containing particles |
| 01/14/2010 | WO2010006177A2 Muc1, caspase-8,and ded-containing proteins |
| 01/14/2010 | WO2010006072A2 Mtor modulators and uses thereof |
| 01/14/2010 | WO2010006070A1 Method for assessment of folate phenotypes, disease risk, and response to therapy |
| 01/14/2010 | WO2010006048A2 Gene expression profiling for predicting the survivability of prostate cancer subjects |
| 01/14/2010 | WO2010006027A1 Phosphorylated c-erbb2 as a superior predictive theranostic marker for the diagnosis and treatment of cancer |
| 01/14/2010 | WO2010005991A2 Circulating tumor and tumor stem cell detection using genomic specific probes |
| 01/14/2010 | WO2010005982A2 Multiplexed biomarkers of insulin resistance |
| 01/14/2010 | WO2010005908A2 Integrated blood glucose measurement device |
| 01/14/2010 | WO2010005858A1 Vaccine for the treatment of alzheimer's disease |
| 01/14/2010 | WO2010005738A1 Chemical sensors and methods for making and using the same |
| 01/14/2010 | WO2010005718A1 Systems and methods for diagnosis and prognosis of cancer |
| 01/14/2010 | WO2010005708A2 Improved folding of recombinant proteins via co-expression of archaeal chaperones |
| 01/14/2010 | WO2010005696A1 Diagnosis and treatment of tumors and metastases |
| 01/14/2010 | WO2010005617A2 Multi-sample particle analyzer system and method for high throughput screening |
| 01/14/2010 | WO2010005593A1 Systems and methods of droplet-based selection |
| 01/14/2010 | WO2010005531A2 Methods for the detection of advanced glycation endproducts and markers for disease |
| 01/14/2010 | WO2010005444A1 Polynucleotide capture materials, and methods of using same |
| 01/14/2010 | WO2010005387A1 New method and biomarkers for the diagnosis of multiple sclerosis |
| 01/14/2010 | WO2010005296A1 Polypeptides involved in the neuroregeneration-promoting properties of olfactory ensheathing glia |
| 01/14/2010 | WO2010005172A1 Bio-sensor |
| 01/14/2010 | WO2010005163A1 Electrochemical bio-sensing and measuring method using the same |
| 01/14/2010 | WO2010005078A1 Cell dispersion method, cell dispersing agent, and cell measurement method |
| 01/14/2010 | WO2010005077A1 Disease-related protein for parkinson’s disease, and use thereof |
| 01/14/2010 | WO2010005069A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | WO2010005067A1 Reagent for detecting type of allele based on polymorphism of siglec14 gene |
| 01/14/2010 | WO2010005046A1 Anti-angiogenic agent |
| 01/14/2010 | WO2010004962A1 Method for detection of fibromyalgia |
| 01/14/2010 | WO2010004923A1 Biomarker for detection of arteriosclerotic disease, and method for detection of arteriosclerotic disease |
| 01/14/2010 | WO2010004777A1 Labeling inorganic nanoparticle agent |
| 01/14/2010 | WO2010004774A1 Silicon nanoparticle suspension, and labeling agent for biological substance |
| 01/14/2010 | WO2010004737A1 Method for determination of potential depression patient |
| 01/14/2010 | WO2010004736A1 Biosensor utilizing dna as element |
| 01/14/2010 | WO2010004695A1 Sequencer |
| 01/14/2010 | WO2010004568A1 Device, method and kit for in vivo detection of a biomarker |
| 01/14/2010 | WO2010004567A1 Method, kit and system for culturable cell count |
| 01/14/2010 | WO2010004416A2 Method and relative apparatus for carrying out diagnostic analyses |
| 01/14/2010 | WO2010004352A1 System of vehicle's tank with built-in detector of adulterated fuel |
| 01/14/2010 | WO2010004336A2 Stimulated cell standards |
| 01/14/2010 | WO2010004244A1 Sample carrier for effecting chemical assays |
| 01/14/2010 | WO2010004241A1 Apparatus and methods for effecting chemical assays |
| 01/14/2010 | WO2010004225A2 Nanoporous detectors of monocyclic aromatic compounds and other pollutants |
| 01/14/2010 | WO2010004214A1 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 01/14/2010 | WO2010004177A2 Method for preventing a vehicle engine from running |
| 01/14/2010 | WO2010004136A2 Triaxial cell for the testing of geomaterials in compression and in shear |
| 01/14/2010 | WO2010004135A1 Triaxial cell for the testing of geomaterials in compression and in tension |
| 01/14/2010 | WO2010003908A1 Screening assay for compounds targeting the p97 aaa-atpase complex in the ubiquitin proteasome system. |
| 01/14/2010 | WO2010003776A1 Means and methods for determining the arteriosclerotic stenosis using inflammatory biomarkers |
| 01/14/2010 | WO2010003691A2 BIOCONJUGATES COMPRISING Aβ-AUTOANTIBODY SPECIFIC EPITOPES FOR ACTIVE IMMUNOTHERAPY AND DIAGNOSIS OF ALZHEIMER'S DISEASE |
| 01/14/2010 | WO2010003602A1 New therapeutic and diagnostic methods for alzheimer's disease |
| 01/14/2010 | WO2010003447A1 Method for on-site drug detection in illicit drug samples |
| 01/14/2010 | WO2010003310A1 Detection device for fluid sample |
| 01/14/2010 | WO2010003307A1 Nitric oxide and its information transfer system are used in detecting tumors |
| 01/14/2010 | WO2010003240A1 Gmcsf and truncated ccl2 conjugates and methods and uses thereof |
| 01/14/2010 | WO2010003231A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/14/2010 | WO2010003230A1 Monoclonal antibodies developed to clostridium botulinum flagellin proteins: novel detection reagents |
| 01/14/2010 | WO2010003227A1 Detection of protein aggregates |
| 01/14/2010 | WO2010003170A1 Novel receptor hetero-dimers/-oligomers |
| 01/14/2010 | WO2009144677A3 Profiles of volatile hydrocarbons, markers of degradation and ageing of cellulosic material and of pathology |
| 01/14/2010 | WO2009143278A3 Methods of diagnosing and characterizing cannabinoid signaling in crohn's disease |
| 01/14/2010 | WO2009143079A3 Methods, devices, kits and compositions for detecting roundworm |
| 01/14/2010 | WO2009143067A3 Methods, devices, kits and compositions for detecting whipworm |
| 01/14/2010 | WO2009142735A3 LUCIFERASE BIOSENSORS FOR cAMP |
| 01/14/2010 | WO2009140754A8 An anti-cancer cytotoxic monoclonal antibody |
| 01/14/2010 | WO2009138408A3 Methods and kits for the diagnosis of rheumatoid arthritis |
| 01/14/2010 | WO2009137768A3 Oxygen and carbon dioxide sensing |
| 01/14/2010 | WO2009137138A3 Methods of analyzing samples for bacteria using whole cell capture and atp analysis |
| 01/14/2010 | WO2009137045A3 Crystal structure of aldehyde dehydrogenase and methods of use thereof |
| 01/14/2010 | WO2009131422A3 SCREENING METHOD FOR THERAPEUTIC AGENTS FOR NEUROLOGICAL DISORDERS USING GABA B RECEPTOR AND PROTEIN KINASE A-α |
| 01/14/2010 | WO2009129628A8 Integrated shear-vertical surface acoustic wave and surface plasmon resonance sensing device and method. |
| 01/14/2010 | WO2009129472A3 Methods of labeling biological samples |
| 01/14/2010 | WO2009126649A3 Method of providing particles having biological-binding areas for biological applications |
| 01/14/2010 | WO2009125989A3 New signal amplification technique for mass analysis |
| 01/14/2010 | WO2009121728A3 Determining the concentration of water treatment chemicals |
| 01/14/2010 | WO2009116000A3 Intravascular sensor and insertion set combination |
| 01/14/2010 | WO2009111308A3 A method to assess stability of proteins |
| 01/14/2010 | WO2009089130A3 Apparatus and method for determining analyte content in a fluid |
| 01/14/2010 | WO2008139259A9 Fluorescent proteins for monitoring intracellular superoxide production |
| 01/14/2010 | WO2008131192A3 Crystalline cholestrol and prevention of atherosclerosis |
| 01/14/2010 | WO2008109709A3 Fluorescent phantom device for light imaging systems |
| 01/14/2010 | WO2006116167A8 Method for determination of glycoprotein ibalpha (gpibalpha) protein |
| 01/14/2010 | WO2006014505A9 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/14/2010 | WO2005097421A9 Methods for identifying risk of osteoarthritis and treatments thereof |
| 01/14/2010 | WO2005072050A9 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 01/14/2010 | WO2003012125A9 Mre11: modulation of cellular proliferation |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100011452 Chimeric non-human animal |
| 01/14/2010 | US20100010748 Method and system for DNA analysis |
| 01/14/2010 | US20100010375 Device and method for analyzing body fluids |
| 01/14/2010 | US20100010373 Quantitative analysis of a biological sample of unknown quantity |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010203 Anti-hydroxylase antibodies and uses thereof |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010075 COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED |
| 01/14/2010 | US20100010056 Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists |
| 01/14/2010 | US20100010009 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl porteinase inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009938 Method to identify and treat subjects resistant to acetyl salicylic acid |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009905 Compositions and Methods for Detection, Prognosis and Treatment of Colon Cancer |